Iowa Admin. Code r. 657-10.38 - [Rescinded effective 7/16/2025] Revision of controlled substances schedules
(1)
Designation of new controlled substance. The board may
designate any new substance as a controlled substance to be included in any of
the schedules in Iowa Code chapter 124 no sooner than 30 days following
publication in the Federal Register of a final order so designating the
substance under federal law. Designation of a new controlled substance under
this subrule shall be temporary as provided in Iowa Code section
124.201(4).
(2)
Objection to designation of a new
controlled substance. The board may object to the designation of any
new substance as a controlled substance within 30 days following publication in
the Federal Register of a final order so designating the substance under
federal law. The board shall file objection to the designation of a substance
as controlled, shall afford all interested parties an opportunity to be heard,
and shall issue the board's decision on the new designation as provided in Iowa
Code section 124.201(4).
(3)
Cannabis-derived
products. If a cannabis-derived product or investigational product
approved as a prescription drug medication by the United States Food and Drug
Administration is added to, eliminated from or revised in the federal schedule
of controlled substances by the DEA and notice of the addition, elimination or
revision is given to the board, the board shall similarly add, eliminate or
revise the prescription drug medication in the schedule of controlled
substances. Such action by the board shall be immediately effective upon the
date of publication of the final regulation containing the addition,
elimination or revision in the Federal Register.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
(1) Designation of new controlled substance. The board may designate any new substance as a controlled substance to be included in any of the schedules in Iowa Code chapter 124 no sooner than 30 days following publication in the Federal Register of a final order so designating the substance under federal law. Designation of a new controlled substance under this subrule shall be temporary as provided in Iowa Code section 124.201(4).
(2) Objection to designation of a new controlled substance. The board may object to the designation of any new substance as a controlled substance within 30 days following publication in the Federal Register of a final order so designating the substance under federal law. The board shall file objection to the designation of a substance as controlled, shall afford all interested parties an opportunity to be heard, and shall issue the board 's decision on the new designation as provided in Iowa Code section 124.201(4).
(3) Cannabidiol investigational product. If a cannabidiol investigational product approved as a prescription drug medication by the United States Food and Drug Administration is eliminated from or revised in the federal schedule of controlled substances by the DEA and notice of the elimination or revision is given to the board , the board shall similarly eliminate or revise the prescription drug medication in the schedule of controlled substances. Such action by the board shall be immediately effective upon the date of publication of the final regulation containing the elimination or revision in the Federal Register.